Literature DB >> 26227667

Guanine polynucleotides are self-antigens for human natural autoantibodies and are significantly reduced in the human genome.

Ittai Fattal1,2,3, Noam Shental4, Shifra Ben-Dor5, Yair Molad6,7, Armando Gabrielli8, Elisheva Pokroy-Shapira6,7, Shirly Oren6,7, Avi Livneh9, Pnina Langevitz10, Gisele Zandman-Goddard11, Ofer Sarig12, Raanan Margalit13, Uzi Gafter3, Eytan Domany2, Irun R Cohen1.   

Abstract

In the course of investigating anti-DNA autoantibodies, we examined IgM and IgG antibodies to poly-G and other oligonucleotides in the sera of healthy persons and those diagnosed with systemic lupus erythematosus (SLE), scleroderma (SSc), or pemphigus vulgaris (PV); we used an antigen microarray and informatic analysis. We now report that all of the 135 humans studied, irrespective of health or autoimmune disease, manifested relatively high amounts of IgG antibodies binding to the 20-mer G oligonucleotide (G20); no participants entirely lacked this reactivity. IgG antibodies to homo-nucleotides A20, C20 or T20 were present only in the sera of SLE patients who were positive for antibodies to dsDNA. The prevalence of anti-G20 antibodies led us to survey human, mouse and Drosophila melanogaster (fruit fly) genomes for runs of T20 and G20 or more: runs of T20 appear > 170,000 times compared with only 93 runs of G20 or more in the human genome; of these runs, 40 were close to brain-associated genes. Mouse and fruit fly genomes showed significantly lower T20/G20 ratios than did human genomes. Moreover, sera from both healthy and SLE mice contained relatively little or no anti-G20 antibodies; so natural anti-G20 antibodies appear to be characteristic of humans. These unexpected observations invite investigation of the immune functions of anti-G20 antibodies in human health and disease and of runs of G20 in the human genome.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  antigens/peptides/epitopes; autoantibodies; human

Mesh:

Substances:

Year:  2015        PMID: 26227667      PMCID: PMC4610629          DOI: 10.1111/imm.12514

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  G-quadruplex DNA structures--variations on a theme.

Authors:  T Simonsson
Journal:  Biol Chem       Date:  2001-04       Impact factor: 3.915

2.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.

Authors:  Adam Siddiqui-Jain; Cory L Grand; David J Bearss; Laurence H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

3.  DNA tetraplex formation in the control region of c-myc.

Authors:  T Simonsson; P Pecinka; M Kubista
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

4.  Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1.

Authors:  K Yanase; R M Smith; A Puccetti; L Jarett; M P Madaio
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay.

Authors:  J L Mergny; L Lacroix; M P Teulade-Fichou; C Hounsou; L Guittat; M Hoarau; P B Arimondo; J P Vigneron; J M Lehn; J F Riou; T Garestier; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA.

Authors:  J Herkel; N Erez-Alon; A Mimran; R Wolkowicz; A Harmelin; P Ruiz; V Rotter; I R Cohen
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA.

Authors:  Ittai Fattal; Noam Shental; Yair Molad; Armando Gabrielli; Elisheva Pokroy-Shapira; Shirly Oren; Avi Livneh; Pnina Langevitz; Rachel Pauzner; Ofer Sarig; Uzi Gafter; Eytan Domany; Irun R Cohen
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

9.  Structure and dynamics of interstrand guanine association in quadruplex telomeric DNA.

Authors:  T Miura; G J Thomas
Journal:  Biochemistry       Date:  1995-07-25       Impact factor: 3.162

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  1 in total

1.  SLE-key(®) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(®).

Authors:  Chaim Putterman; Alan Wu; Anat Reiner-Benaim; D Scott Batty; Ignacio Sanz; Jim Oates; Keren Jakobi; Michelle Petri; Pennina Safer; Robert Gerwien; Rachel Sorek; Yakov Blumenstein; Irun R Cohen
Journal:  J Immunol Methods       Date:  2015-12-08       Impact factor: 2.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.